IP Library › Granted Patent US 8,980,844
Granted Patent B2
US 8,980,844 · App. 13/703,565 · Granted Mar 17, 2015

Peptide having antibacterial or anti-inflammatory activity and pharmaceutical composition containing the same as an active ingredient

Inventors: Chong-Pyoung Chung (Seoul, KR); Yoon-Jeong Park (Seoul, KR); Jue-Yeon Lee (Gyeonggi-do, KR)
Assignee: Nano Intelligent Biomedical Engineering Corporation Co. Ltd.
C07K14/4723A61K38/10A61K38/16A61K38/17A61K38/18A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,980,844
App. No.
13/703,565
Granted
Mar 17, 2015
Kind
B2
Abstract

A peptide having antibacterial or anti-inflammatory activity and a pharmaceutical composition containing the same as an active ingredient are described. Also, a peptide having antibacterial or anti-inflammatory activity against dental bacteria, including periodontal pathogens, and bacteria causing atopic dermatitis, and a pharmaceutical composition containing the peptide as an active ingredient are described. The inventive peptide having antibacterial or anti-inflammatory activity can be used for the treatment of both dental infectious diseases, including periodontitis, and inflammations, including arthritis.

Claims (8)

1. An antibacterial composition containing the isolated peptide consisting of an amino acid sequence of SEQ ID NO: 2 as an active ingredient.

2. A composition for treating dental infectious disease containing the isolated peptide consisting of an amino acid sequence of SEQ ID NO: 2 as an active ingredient.

3. The composition of claim 2 , wherein the dental infectious disease is selected from the group consisting of gingivitis, periodontitis, and peri-implantitis.

4. The composition of claim 2 , wherein the composition is formulated in the form of a gel.

5. The composition of claim 2 , further comprising a pharmaceutically acceptable carrier.

6. The composition of claim 5 , wherein the composition is formulated in the form of a gel.

7. The composition of claim 1 , wherein the composition contains the peptide in an amount of 10 −3 to 1 part by weight.

8. The composition of claim 2 , wherein the composition contains the peptide in an amount of 10 −3 to 1 part by weight.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2013
From: CHUNG, CHONG-PYOUNG; PARK, YOON-JEONG; LEE, JUE-YEON
To: NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO. LTD.
Reel/Frame 029788/0182 →
Priority Claims (5)
KR 10-2010-0057000 · Jun 16, 2010 · national
KR 10-2010-0118184 · Nov 25, 2010 · national
KR 10-2010-0118185 · Nov 25, 2010 · national
KR 10-2010-0118186 · Nov 25, 2010 · national
KR 10-2010-0118187 · Nov 25, 2010 · national
Continuity (1)
Related Publication 20130210707A1 · Aug 15, 2013